Natixis Burning Rock Biotech LTD Transaction History

Natixis

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.75 - $10.44 $86,259 - $514,598	-49,291 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.7 - $10.23 $22,485 - $34,331	-3,356 Reduced 6.37%	49,291 $458,000
Q4 2021 Feb 14, 2022	SELL	$9.43 - $17.14 $21,981 - $39,953	-2,331 Reduced 4.24%	52,647 $502,000
Q3 2021 Nov 12, 2021	SELL	$17.37 - $27.92 $69,896 - $112,350	-4,024 Reduced 6.82%	54,978 $983,000
Q2 2021 Aug 13, 2021	SELL	$26.14 - $37.45 $25,564 - $36,626	-978 Reduced 1.63%	59,002 $1.74 Million
Q1 2021 May 14, 2021	BUY	$23.5 - $39.58 $1.41 Million - $2.37 Million	59,980 New	59,980 $1.62 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $705M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.